US scrutiny of billionaire’s sprawling finance holdings reached beyond insurers into securities and asset management giant
Related stories
An overlooked energy source could solve AI’s power crunch — and these 2 stocks are prime plays
Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.
America’s renters are in serious trouble
Trump faces midterm reckoning in Pennsylvania’s ‘swingiest’ district
Former Weil partners lawyer up over firm’s wind-down
Once election results are in, here’s what investors should focus on next